Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy
NCT07374861 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2026-01-29
Summary
Evaluation of adherence, persistence, and efficacy of treatment with Bempedoic acid in a real-life Italian population.
Conditions
Interventions
- DRUG
-
film-coated tablets
Sponsors & Collaborators
-
Federico II University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-04
- Primary Completion
- 2026-12-31
- Completion
- 2028-12-31
- FDA Drug
- Yes
Countries
- Italy
Study Locations
More Related Trials
-
A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
NCT06686615 ·Status: RECRUITING
-
Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia
NCT00141141 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Simvastatin on Apolipoprotein B-100 (apoB-100) Secretion
NCT00905541 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy
NCT03337308 ·Status: COMPLETED ·Phase: PHASE3
-
Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia
NCT00557778 ·Status: COMPLETED
-
Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia
NCT04579367 ·Status: ACTIVE_NOT_RECRUITING
-
Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED)
NCT00935259 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
NCT00349375 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-term Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia
NCT05687071 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia
NCT04784442 ·Status: COMPLETED ·Phase: PHASE2
-
National Survey on Dyslipidemic Patients
NCT00701402 ·Status: COMPLETED
-
Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
NCT00300456 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
NCT00309738 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
NCT02988115 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
NCT00309777 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin
NCT07235189 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol
NCT01004705 ·Status: TERMINATED ·Phase: PHASE2
-
Drug-drug Interaction of Empagliflozin (BI 10773) and Simvastatin
NCT01304329 ·Status: COMPLETED ·Phase: PHASE1
-
A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease
NCT01674712 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia
NCT06173570 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia
NCT00487591 ·Status: COMPLETED
-
Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
NCT00352183 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Observational Program Using Digital Technology Tools to Enhance Patient Adherence to Omacor Therapy
NCT03415152 ·Status: COMPLETED
-
Study of A3309 in Patients With Dyslipidemia
NCT01069783 ·Status: COMPLETED ·Phase: PHASE2
-
Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
NCT02015988 ·Status: UNKNOWN ·Phase: PHASE4